• Journal Article

Quantitative benefit-risk tradeoff preferences for Crohn’s Disease treatments: Implications for regulatory decision making and disease management

Citation

Johnson, F., Hauber, A., Ozdemir, S., Siegel, C. A., Sands, B. E., & Hass, S. (2009). Quantitative benefit-risk tradeoff preferences for Crohn’s Disease treatments: Implications for regulatory decision making and disease management. International Journal of Medical and Biological Frontiers, 15(5/6), 457-466.

Abstract